Adagio(IVVD) - 2023 Q4 - Annual Results

Exhibit 99.1 Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights WALTHAM, Mass., March 28, 2024 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases, today announced financial results for the full year ended December 31, 2023 and recent business highlights. Mr. Hering continued, "With PEMGARDA now authorized and anticipated to be available for order in the U.S. imminently, we are ...